Addressing stigmatized industries
As society gradually becomes more normal to discuss taboo topics (menstruation, menopause, sexual health, violence, etc.), companies are increasingly starting to directly address products in these segments.
As the segments of menopause and menstrual health solutions grow, more companies will emerge that address topics that are not yet commonly discussed.
Solutions in the 65+ category
The global population of people aged 65 and over is growing faster than any other age group. Among other things, this is an affluent audience for whom it is already quite common to use digital products and technologies.
Products in the field of fertility and reproductive health, as one turkey number data of the anchor segments, which also attracts not only women, but also men, will develop.
trend of scaling FemTech startups and "capturing" related segments. For example, the same unicorn Maven started its work as a product for pregnancy, gradually becoming a full-fledged platform for reproductive health. And the company's immediate plans include entering the menopause segment.
Will FemTech Be the Next Big Thing in Healthcare?
Women make up half of the world's population, but despite an annual healthcare expenditure of $500 billion attributed to them, only 4% of all healthcare research and development is directed at addressing women's health issues. FemTech remains a very underdeveloped area of medical technology.
And even though investment in the global FemTech market is growing, companies specializing in solutions to improve women's health still represent only a small fraction of all players in the healthcare industry. The main reasons are the taboo surrounding the female body, as well as the low representation of women in management.